[Chimiotherapy of cancers (operational research of its efficiency and its place in therapeutic strategy of neoplasic diseases)].
D000380:Agranulocytosis / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D003520:Cyclophosphamide / Q000008:administration & dosage; D003630:Daunorubicin / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D007958:Leukocyte Count; D008727:Methotrexate / Q000008:administration & dosage; D009369:Neoplasms / Q000532:radiotherapy / Q000601:surgery; D009360:Neoplastic Cells, Circulating; D011241:Prednisone / Q000627:therapeutic use; D014747:Vinblastine / Q000008:administration & dosage; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D014750:Vincristine; D014747:Vinblastine; D003520:Cyclophosphamide; D011241:Prednisone; D008727:Methotrexate; D003630:Daunorubicin
La chimiothérapie des cancers (La recherche opérationnelle de son efficacité et sa place dans la stratégie therapeutique des maladies néoplasiques)